Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1184714Generated: October 26, 2026

5-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(tris(propan-2-yl)silyl)-1,3-oxazole → 4-[5-(2-Triisopropylsilanyl-oxazol-5-yl)-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carboxylic acid tert-butyl ester

https://huagongshe.com/reaction/1184714

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(tris(propan-2-yl)silyl)-1,3-oxazoleHCID 44224311—
Reactant4-(5-Chloro-2,3-dihydrofuro[2,3-c]pyridin-2-yl)piperidine-1-carboxylic acid tert-butyl esterHCID 86674895—
Product4-[5-(2-Triisopropylsilanyl-oxazol-5-yl)-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carboxylic acid tert-butyl esterHCID 67973538—

Reaction Steps

The title compound is prepared from 4-(5-chloro-2,3-dihydro-furo[2,3-c]pyridin-2-yl)-piperidine-1-carboxylic acid tert-butyl ester and 5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2-triisopropylsilanyl-oxazole following a procedure analogous to that described for Intermediate 15. LC (method 10): tR=2.02 min; Mass spectrum (ESI+): m/z=528 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08669271B2
Source datasetuspto-grants-2014_03
ORD IDord-82969d96aac6417a8f025214e5d45234
Source noteuspto-grants-2014_03